SEARCH

SEARCH BY CITATION

References

  • 1
    Hamming JF, Van de Velde CJ, Goslings BM, Shelfhout LJ, Fleuren GJ, Hermans J, et al. Prognosis and morbidity after total thyroidectomy for papillary, follicular and medullary thyroid cancer. Eur J Cancer Clin Oncol 1989; 25: 131723.
  • 2
    Donohue JH, Goldfien SD, Miller TR, Abele JS, Clark OH. Do the prognoses of papillary and follicular thyroid carcinomas differ? Am J Surg 1984; 148: 16873.
  • 3
    Vigneri R. Studies on the goiter endemic in Sicily. J Endocrinol Invest 1988; 11: 83143.
  • 4
    Harness JK, Thompson NW, McLeod MK, Eckhauser FE, Lloyd RV. Follicular carcinoma of the thyroid gland: trends and treatment. Surgery 1984; 96: 97280.
  • 5
    Young RL, Mazzaferri EL, Rahe AJ, Dorfman SG. Pure follicular thyroid carcinoma: impact of therapy in 214 patients. J Nuclear Med 1980; 21: 7337.
  • 6
    Brennan MD, Bergstrahl EK, van Heerden JA, McConahey WM. Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc 1991; 66: 1122.
  • 7
    Hirabayashi RN, Lindsay S. Carcinoma of the thyroid gland: a statistical study of 390 patients. J Clin Endocrinol 1961; 21: 1596610.
  • 8
    Mazzaferri EL. Treating differentiated thyroid carcinoma: where do we draw the line? [editorial]. Mayo Clin Proc 1991; 66: 10511.
  • 9
    Hawk WA, Hazard JB. The many appearances of papillary carcinoma of the thyroid. Cleve Clin Q 1976; 43: 20715.
  • 10
    Buckwalter JA, Thomas CG Jr. Selection of surgical treatment for well differentiated thyroid carcinomas. Ann Surg 1972; 176: 56578.
  • 11
    DeGroot LJ, Kaplan EL, McCormick M, Staus FH. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 1990; 71: 41424.
  • 12
    Endocrine tumors: diagnosis, treatment, pathophysiology. Bethesda, MD: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, International Cancer Research Data Bank. 1991 Cancergram, Series CT21.
  • 13
    Hay ID, Grant CS, Taylor WF, McConahey WM. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987; 102: 108895.
  • 14
    Simpson WJ, McKinney SE, Carruthers JS, Gospodarowicz MK, Sutcliffe SB, Panzarella T. Papillary and follicular thyroid cancer: prognostic factors in 1,578 patients. Am J Med 1987; 83: 47988.
  • 15
    Siperstein AE, Zeng QH, Gum ET, Levin KE, Clark OH. Adenylate cyclase activity as a predictor of thyroid tumor aggressiveness. World J Surg 1988; 12: 52833.
  • 16
    Lowhagen T, Granberg PO, Lundell G, Skinnari P, Sundblad R, Willems JS, et al. Aspiration biopsy cytology (ABC) in nodules of the thyroid gland suspected to be malignant. Surg Clin North Am 1979; 59: 318.
  • 17
    Gharib H, Goelliner JR, Zinsmeister AR, Grant SG, van Heerden JA. Fine needle aspiration biopsy of the thyroid. Ann Intern Med 1984; 101: 258.
  • 18
    Rojeski MT, Gharib H. Nodular thyroid disease. N Engl J Med 1985; 313: 42836.
  • 19
    Crile G Jr., Pontius KI, Hawk WA. Factors influencing the survival of patients with follicular carcinoma of the thyroid gland. Surg Gyn Obstet 1985; 160: 40913.
  • 20
    Schmidt RJ, Wang CA. Encapsulated follicular carcinoma of the thyroid: diagnosis, treatment, and results. Surgery 1986; 100: 106876.
  • 21
    de los Santos ET, Keyhani-Rofagha S, Cunningham JJ, Mazzaferri EL. Cystic thyroid nodules: the dilemma of malignant lesions. Arch Intern Med 1990; 150: 14227.
  • 22
    Rosen IB, Provias JP, Walfish PG. Pathologic nature of cystic thyroid nodules selected for surgery by needle aspiration biopsy. Surgery 1986; 100: 60613.
  • 23
    Blum M, Goldman AB, Herkovic A. Clinical applications of thyroid echography. New Engl J Med 1972; 287: 116486.
  • 24
    Ashcraft MW, Van Herle AJ. Management of thyroid nodules. II: Scanning techniques, thyroid suppressive therapy, and fine needle aspiration. Head Neck Surg 1981; 3: 297322.
  • 25
    Beierwaltes WH, Nishiyama RH, Thompson NW, Copp JE, Kubo A. Survival time and “cure” in papillary and follicular carcinoma with distant metastases: statistics following University of Michigan therapy. J Nucl Med 1982; 23: 40311.
  • 26
    Block BL, Spigel JC, Chami RG. The treatment of papillary and follicular carcinoma of the thyroid. Otolaryngol Clin N Am 1990; 23: 40311.
  • 27
    Levin KE, Clark OH, Duh QY, Demeure M, Siperstein AE, Clark OH. Reoperative thyroid surgery. Surgery 1992; 111: 6049.
  • 28
    Clark OH. TSH suppression of thyroid nodules and thyroid cancer. World J Surg 1981; 5: 3946.
  • 29
    Schlumberger J, Tubiana M, DeVathaire F, Hill C, Gardet P, Travagli JP, et al. Long term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinomas. J Clin Endocrin Metab 1986; 663: 96070.
  • 30
    Black EG, Cassone A, Gimlette TMD. Serum thyroglobulin in thyroid cancer. Lancet 1981; 2: 4435.
  • 31
    Lang W, Choritz H, Hundeshagen H. Risk factors in follicular thyroid carcinomas: a retrospective follow-up study covering a 14-year period with emphasis on morphological findings. Am J Surg Pathol 1986; 10: 24655.
  • 32
    Schelfhout LJ, Creuzberg CL, Hamming JF, Fleuren GJ, Smeenk D, Hermans J, et al. Multivariate analysis of survival in differentiated thyroid cancer: the prognostic significance of the age factor. Eur J Cancer Clin Onc 1988; 24: 3317.
  • 33
    Brooks JR, Starnes HF, Brooks DC, Pelkey JN. Surgical therapy for thyroid carcinoma: a review of 1249 solitary thyroid nodules. Surgery 1988; 104: 9406.
  • 34
    Duh QY, Clark OH. Factors influencing the growth of normal and neoplastic thyroid tissue. Surg Clin North Am 1987; 67: 28198.